Science Round-up: Boeing rocket for NASA over budget could further delay launch and more


Devdiscourse News Desk | Updated: 11-10-2018 11:07 IST | Created: 11-10-2018 10:27 IST
Science Round-up: Boeing rocket for NASA over budget could further delay launch and more
Image Credit: Wikipedia

Boeing rocket for NASA over budget could further delay launch: audit

Boeing Co is building the largest rocket in NASA's history but the aerospace giant's "poor performance" has resulted in an $8.9 billion price tag that is double the initial budget and could further delay the launch, the U.S. space agency's watchdog office said on Wednesday. The first test launch of the Space Launch System rocket, which is supposed to send humans to the moon and ultimately allow deep space exploration, was most recently slated for mid-2020 with a crew launch to follow in 2022. The launches have been delayed at least three times.

J&J's Stelara succeeds in chronic bowel disease study

Johnson & Johnson said on Tuesday its blockbuster drug Stelara was found to be effective in treating a chronic bowel disease in a late-stage trial. Two doses of Stelara, already approved for psoriasis, psoriatic arthritis and Crohn's disease, was tested in 961 patients with moderate-to-severe ulcerative colitis (UC) who had failed prior therapy.

(With inputs from agencies.)

Give Feedback